Dr. David Samadi and Urology Mastery

Dr. David B. Samadi is a famous Lenox Hill Hospital employee. He’s its Chief of Robotic Surgery and Chairman of Urology at the moment. This hospital is in New York, New York’s Upper East Side. Dr. David Samadi is a professional who has board certification. He’s a urologist who knows how to accommodate patients who have all different kinds of urological health conditions. He regularly accommodates patients who have bladder cancer, prostate cancer and even kidney cancer. His focus is on state of the art treatment options that aren’t highly invasive in nature. He knows a lot about prostate cancer treatments like laparoscopic robotic radical prostatectomy and laparoscopic radical prostatectomy.

Dr. David Samadi initially worked for Columbia Presbyterian Hospital. He after that was part of the Icahn School of Medicine at Mount Sinai. That was in 2007. Dr. Samadi was the Department of Urology’s Vice Chair there.

This healthcare professional has a devotion to his field that’s unequaled. He’s enthusiastic about numerous professional organizations. These include groups like the American Medical Association and the American Urological Association. He takes part in these organizations’ efforts all of the time. He often showcases his clinical studies while in attendance at conferences that delve into medical matters of all types. He goes to conferences that take place in locations all over the United States. He goes to many global conferences as well.

Dr. David Samadi generally conducts roughly 15 surgical treatments for prostate cancer patients each week. He has modern and innovative equipment on his side at all times. His work setting is accommodating as well. Patients who experience care from Dr. Samadi can always revel in full serenity.

This surgeon has an educational track record that’s highly impressive. He went to Roslyn High School located in Roslyn Heights, New York between the years of 1983 and 1984. That was merely the beginning of his dazzling educational and training experience. He studied at Stony Brook’s State University of New York for some time. He had a scholarship and learned about biochemistry in significant detail.

Dr. David B. Samadi has a zeal for his profession that many others cannot touch. He routinely talks to people about all types of subjects that involve health, too. He talks about subjects that relate to reducing triglycerides. He talks about what people everywhere can do to be a lot less vulnerable to conditions such as cancer as well.

For More info: www.huffingtonpost.com/author/dr-david-samadi

SMART Dr. David Samadi

David Samadi grew up in a Persian Jewish community located in Iran. After the Iranian Revolution in 1979, the 15-year-old David and his brother had to relocate. They continued their education in London. Shortly after, they left London to go to the United States. In 1983 David attended Rosylin High School in New York, where he was president of his class and followed several programs that allowed him the opportunity to acquire his bachelor’s degree in science. He earned his biochemistry degree on a full scholarship while he was a student at Stony Brook University. In 1994 he earned his M.D from S.U.N.Y Stony Brook School of Medicine. David Samadi is now a board-certified Urologic oncologist, chief of robotic surgery and chairperson of urology at Lenox Hill Hospital in New York.To better accommodate his patient’s recovery of prostate cancer, Dr. Samadi developed a robotic technique called SMART.

This technique removes prostate cancer cells and allows the patient to have urinary control and sexual activities after surgery.Concerned that not everyone has access to medical professionals. Dr. David Samadi wanted to bring awareness about health issues with Dr. Samadi TV. This is where he provides the public with important topics and advice for good health. He broadcast live every Sunday at 12:30 p.m. and has a variety of social media presence. Along with his own website Dr. David has accounts on Facebook, Twitter, Instagram, YouTube and many more. His compassion for his patients has won him multiple awards and recognitions, most of which, he wins years in a row. He won Most Compassionate Doctor for three years, America’s Top Doctors for Cancer five years in a row, America’s Top Doctors award five years in a row and several more awards.

When Mitt Romney was diagnosed with prostate cancer, he had two choices of treatment, radiation or surgery. Although there are many complications involved with both, Dr. David Samadi recommends surgery. Mitt Romney underwent the surgery and was cleared of his prostate cancer.During his interview with Ideamensch, Dr. David Samadi described a typical day for him at work. He starts his day early, 4:30 a.m. to be exact. The doctor was asked how he imagines his ideas and makes them a reality, his response was the fact that he has a photographic memory and finds himself sketching his ideas. In this interview he talks about his development of the SMART technique that will help doctors avoid damage to the nerves and sphincter during surgery. He recommends we read a book, “Anything is Possible”, by Elizabeth Strout for anyone in troubling times.

Cancer Treatment Centers of America And National Football League Alumni Association Work Together for Prostate Cancer

Prostate cancer is a major problem. It has been such a huge concern that the National Football League has teamed up with Cancer Treatment Centers of America in order to bring about more opportunities for screenings. This opportunity has started up in September and has gone until Oct 15. One of the issues with prostate cancer is that it affects one in seven men. Therefore, it is an huge issue, especially for men past the age of 40. There are other risk factors to look out for with prostate cancer. It is up to each individual to make sure that he is getting the regular checks so that he can avoid prostate cancer.

CTCA is one of the best facilities for getting cancer treatment. There is a ton of information available at the center that can provide people with insight on what cancer is and what they can do to maximize the effectiveness of treatment. For one thing, the current form of treatment which is chemotherapy comes with plenty of side effects since it is an antibiotic. Among the side effects are hair loss, disruptions of cognitive abilities and other side effects that could interfere with their daily lives.

One of the best things about CTCA is that they take the time to provide information on what can be done about the side effects so that people can recover better from cancer. One of the best things about getting information about cancer is that this equips people to make sure that they are able to recover in the best way. Also, the partnership of CTCA with the NFL is very helpful in that it spreads awareness of prostate cancer through one of the most enjoyed sport in America. Tons of football fans are aware of the disease and are willing to help sufferers.

Mikhail Blagoskylonny’s Accomplishments as an Oncology Expert

Mikhail Blagoskylonny is a New York-based professor of oncology who has gained global recognition due to his outstanding research in cancer and aging. The scientist has made significant discoveries that have greatly helped in improving the oncology sector. He currently does his research work at the Rosewell Park Cancer Institute and has been serving it as a professor since 2009. The scientist has also been involved in writing and publishing a couple of valuable material that focuses on aging and cancer. He is recognized for encouraging medical professionals across the globe to use Rapamycin in prolonging the lives of their patients. Blagoskylonny has gained respect in the medical research field due to his excellent knowledge of oncology.According to the scientist’s research work, Rapamycin has outstanding properties that can make it the best drug for treating cancer. The medicine is currently used for curing other life-threatening conditions that include lymphangioleiomyomatosis (LAM), hemolytic-uremic syndrome, tuberous sclerosis complex (TSC), and facial angiofibromas.

It can be accessed in pharmacies across the globe, and its local name is Rapamune. Rapamycin has been used since 1972 when it was discovered from a strain of bacteria that was on Eastern Island. It was initially used as an anti-fungal agent before professionals learned about its properties as an immunosuppressive and antiproliferative.The scientist has been acknowledged for making significant discoveries towards the development targeted cancer therapies. He has also conducted unparalleled researched on ideal cancer and anti-aging cures. Blagosklonny’ believes that cancer is related to aging since it mostly affects individuals who have passed a specific age. He is a role model to his workmates and students due to his accomplishments in the oncology sector.Blagosklonny’s career has blossomed because of his remarkable academic qualification. The professor got his Ph.D. from the First Pavlov State Medical University of St. Peterburg. He was also awarded a masters’ degree in internal medicine from the institution. The scientist’s career began in 2002 when he joined the New York Medical College to work as a researcher.

After gaining some experience, he was hired by the Ordway Research Institute to act as a senior researcher before moving to Roswell Park Cancer Institute in 2009. His role as a professor at the institute has been acknowledged since he has assisted in the invention of various targeted cancer treatments. Mikhail has also studied a lot about the aging mechanism and anti-aging drugs development. The latest research project that he is conducting is focused on discovering how aging and cancer are affected by the TOR signal.Mikhail Blagoskylonny has also established a successful career as an editor in different fields in the medical research industry. The professor has excellent knowledge of the cell cycle, aging, and oncotaget and is currently an editor-in-chief in all the areas. He has also been chosen to serve as an editor in research fields such as cancer biology and therapy. The publications that he has written are currently used by researchers and professionals who are interested in acquiring knowledge about oncology.

Why Eric Lefkofsky Is A Medical Technology Warrior

Cancer is a cruel and puzzling foe that has confounded mankind since its beginning. A disease that causes one’s body to become one’s own worst enemy, cancer seems to have any number of causes, but no apparent cures. Unless one is lucky enough to be declared cancer-free in their battle with it, the best that can be hoped for is to arrest and manage the disease with an array of powerful medications. Unfortunately some of these treatments produce serious and sometimes lethal side effects, and it’s not uncommon to hear that these treatments can be worse than the actual cancer.

Fortunately, technological advances correctly administered now mean that health care providers can create individual biological biographies and administer patient cancer care much more effectively. This is made possible in large part through the efforts of Tempus and its co-founder and CEO Eric Lefkofsky.

Tempus is computer software that allows users to map genomes and body functioning on the molecular level in real time, and use this collected data to make decisions about the best course of action involving individual patients. Tempus also delivers a complete report to physicians after patient scanning that includes current information on clinical trials that patients might qualify for, and detailed information on tumors. Tempus also can be used in conjunction with research involving animal trials to develop new types of cancer therapy.

Eric Lefkofsky is no stranger to being involved in shaking up and improving ways of doing things. In addition to his creation and involvement with Tempus, Eric did similar work in setting up Lightbank, a company that funds disruptive technologies. Disruptive technologies are ones that shake up or transform existing technologies. Next-generation genome tracking, self-driving vehicles, natural resource recovery, and cloud platform technologies are all examples of disruptive ones. And not only are these technologies disruptive, they’re transformative, meaning that they’ll impact on how these industries operate far into the future. This means that cancer patients in decades to come will benefit from the efforts of Tempus and Lefkofsky.

In addition to his Tempus and Lightbank work, Lefkofsky has co-founded Uptake, an analytical data company that provides companies with information to help improve company security and safety. In addition to focusing more recently on Tempus, Lefkofsky has become very involved recently in charitable gift giving.

In 2006, he and his wife Elizabeth founded the Lefkofsky Foundation, and since its creation, have given or pledged millions of dollars around the world, including to the Chicago public school system, and a prominent children’s hospital. He is also either a member of or sits on the board of directors of a number of cultural institutions, including the Steppenwolf Theater Company and the Chicago Institute of Art. But Lefkofsky’s touch and instincts aren’t always perfect. He also served on the committee that failed to bring the Summer Olympics to Chicago in 2016.

More information for Lefkofsky: http://www.bizjournals.com/chicago/news/2016/10/20/groupon-founder-eric-lefkofsky-joins-steppenwolf.html

Tech roundup: Lefkofsky’s Tempus comes out of stealth, AddStructure teams up with Target and more